Drug Trial Radar · NCT00532779
A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects
Last checked: Nov 19, 2026Latest source record: Nov 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,742
Actual
Start
Oct 2007
Primary completion
May 2009
Study completion May 2009
Sponsor
- Lead sponsor
- Orexigen Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Sep 20, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether 2 doses of the combination of naltrexone SR and bupropion SR are safe and effective in the treatment of obesity.
Conditions
- Obesity
- Overweight
Interventions
Naltrexone SR 16 mg/Bupropion SR 360 mg /dayDrug
Naltrexone SR 32 mg/Bupropion SR 360 mg /dayDrug
PlaceboDrug
Ancillary therapyBehavioral
Ancillary therapy consisting of diet instruction, advice on behavior modification, and exercise counseling
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-primary: Body Weight- Mean Percent ChangeTime frame: Baseline, 56 weeks
- Co-primary: Body Weight- Proportion of Subjects With ≥5% DecreaseTime frame: Baseline, 56 weeks
Locations
34 sites in 1 country. Site status is shown where the registry gives one.
Radiant Research
Birmingham, Alabama
SelfCenter, PC
Fairhope, Alabama
Radiant Research, Phoenix Southeast
Chandler, Arizona
Advanced Clinical Research Institute
Anaheim, California
Advance Clinical Research Institute
Orange, California
Scripps Clinic Del Mar
San Diego, California
VA San Diego Healthcare System
San Diego, California
Miami Research Associates
Miami, Florida
University Clinical Research
Pembroke Pines, Florida
Georgia Clinical Research
Atlanta, Georgia
CSRA Partners in Health, Inc
Augusta, Georgia
East-West Medical Research Institute
Honolulu, Hawaii
Radiant Research
Chicago, Illinois
Welborn Clinic
Evansville, Indiana
Radiant Research Kansas City
Overland Park, Kansas
Central Kentucky Research Associates, Inc.
Lexington, Kentucky
Pennington Biomedical Research Center
Baton Rouge, Louisiana
Medical Research Institute
Slidell, Louisiana
Health Trends Research, LLC
Baltimore, Maryland
FutureCare Studies
Springfield, Massachusetts
Center for Nutrition and Metabolic Disorders
Reno, Nevada
Center for Nutrition and Preventive Medicine
Charlotte, North Carolina
Wake Research Associates, LLC
Raleigh, North Carolina
Rapid Medical Research, Inc.
Cleveland, Ohio
Central Ohio Nutrition Center, Inc.
Columbus, Ohio
Lynn Health Science Institute
Oklahoma City, Oklahoma
Summit Research Network (Oregon), Inc.
Portland, Oregon
Internal Medicine Associates of Cordova
Cordova, Tennessee
Jackson Clinic, PA
Jackson, Tennessee
Covance Clinical Research Unit Austin
Austin, Texas
Radiant Research
Dallas, Texas
Baylor Endocrine Center
Dallas, Texas
Radiant Research
San Antonio, Texas
Oakwell Clinical Research
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.